Abstract
After waiting in the wings for more than 10 years, monoclonal antibodies are finally finding a place on the clinical stage for the treatment of various cancers. Researchers at the 11th International Conference on Monoclonal Antibodies for Cancer [ California, US; March 1998 ] introduced the latest stars entering the market, as well as promising candidates now entering clinical trials.
Rights and permissions
About this article
Cite this article
Henahan, S. Monoclonal antibodies finding a place in cancer therapy. Inpharma Wkly. 1135, 9–10 (1998). https://doi.org/10.2165/00128413-199811350-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811350-00015